EVALUATION OF PRESCRIBED CARDIOVASCULAR DRUGS MARKETED BY VARIOUS PHARMACEUTICAL COMPANIES OF BANGLADESH
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 3
Abstract
Cardiovascular drugs encompass a large number of prescription medications that are used to control heart disease. It is a complicated group of drugs with many being used for multiple heart conditions. The main objective of this survey was to analyze the prescribed cardiovascular drugs with their brand name marketed by different local and international companies of Bangladesh. This was a descriptive cross-sectional survey involving patients, physicians and pharmacy in-charge based on a structured questionnaire format with answer sets and followed up by prescription monitoring. This study carried out at the outdoor of National Heart Foundation (Mirpur, Dhaka) and the Dhaka medical college hospital Pharmacy (Dhaka, Bangladesh) from January’12 to August’12. From total 700 prescriptions, 99% prescriptions were prescribed by the specialist but only 1% by general physicians. Out of the total patients with a male, female ratio of 57.14: 42.86, all patients were over 30 years and approximately 64.285 % the patients were demographically from urban area whereas 35.714% patients came from rural area. Individual patients got different classes of drugs including Beta-blockers, Organic nitrates, anticoagulant, antiplatelet and thrombolytic agents, Calcium channel blockers, Diuretics, ACE inhibitors, Lipid lowering agents and Miscellaneous agents were respectively 25.00, 19.57, 22.00,8.42,10.42,10.40 and 2.85 percent. This study may be guidelines for optimizing rational use of cardiovascular drugs and also a new statistical approach for effective cardiovascular disease management in Bangladesh.
Authors and Affiliations
Zubair Khalid Labu| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Razia Sultana| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Samiul Basir| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Jalal Uddin| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Afsana Afrin| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,, Nadia Sultana| Department of Pharmacy, World University of Bangladesh, Dhaka 1205, Bangladesh,
Keywords
Related Articles
- EP ID EP1799
- DOI -
- Views 393
- Downloads 26
CLINICAL EVALUATION OF AN IN-OFFICE APPLICATION OF TWO COMMERCIALLY AVAILABLE DENTIFRICES ON DENTINE HYPERSENSITIVITY IN CHRONIC PERIODONTITIS PATIENTS
Aim: To evaluate the clinical effectiveness of an in-office application of desensitizing paste containing 8% arginine calcium carbonate and 5% potassium nitrate paste on dentine hypersensitivity in chronic Periodontitis...
THE APPLICATION OF PROBIOTICS IN DECREASE CANCER
Cancer is one of the most important deaths causing in the world and many factors as chemicals, rays, viruses and genetic factors may influence it. Probiotics, live cells with different beneficiary characteristics, have b...
UV-Visible spectrophotometric detection of Solanum aethiopicumhexanic and n-butanolic excerpts and their anticancer activity monitored by flow cytometry and microscopy
UV-Visible Spectrophotometry (UV-Vis) is one of the most used analytical technics because of its accuracy, however, it application in phytochemicals and extracts characterization still a huge challenge even for the choic...
IS PSEUDOCHOLINESTERASE RELATED TO LIPID METABOLISM IN CORONARY ARTERY DISEASE?
Background: Pseudocholinesterase is a serum esterase synthesized by liver. The physiological function of Pseudocholinesterase is not known. It has been proposed that it plays a role in lipid metabolism. Altered lipid m...
DETECTION OF EXTENDED SPECTRUM BETA - LACTAMASE PRODUCING E. COLI & KLEBSIELLA SPECIES CAUSING URINARY TRACT INFECTION
Extended-spectrum beta-lactamases (ESBLs) constitute a growing class of plasmid-mediated ß-lactamases which confer resistance to broad spectrum beta-lactam antibiotics. The frequency of ESBL producing strains among cli...